+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Matrix Metalloproteinase 9"

Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Matrix Metalloproteinase 9 (MMP-9) is an enzyme that is involved in the breakdown of extracellular matrix components, such as collagen and elastin. It is a member of the matrix metalloproteinase family, which is a group of zinc-dependent endopeptidases that are involved in the degradation of the extracellular matrix. MMP-9 is involved in a variety of physiological and pathological processes, including tissue remodeling, wound healing, and inflammation. It is also involved in the progression of certain diseases, such as cancer and arthritis. MMP-9 is used in a variety of research and clinical applications, including the diagnosis and treatment of diseases, as well as the development of new therapeutic strategies. It is also used in the development of new drugs and biologics. Companies in the MMP-9 market include Abcam, Merck KGaA, Bio-Techne, Thermo Fisher Scientific, and Sigma-Aldrich. Show Less Read more